Literature DB >> 22337279

Prophylaxis for adults with haemophilia: towards a personalised approach?

Massimo Franchini, Pier Mannuccio Mannucci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22337279      PMCID： PMC3320771          DOI： 10.2450/2012.0182-11

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  16 in total

1.  Prophylaxis for adults with haemophilia: one size does not fit all.

Authors:  Kathelijn Fischer
Journal:  Blood Transfus       Date:  2012-04       Impact factor: 3.443

2.  Controversies regarding the prophylactic management of adults with severe haemophilia A.

Authors:  L A Valentino
Journal:  Haemophilia       Date:  2009-12       Impact factor: 4.287

3.  Prophylaxis in haemophilia should be life-long.

Authors:  Mike Makris
Journal:  Blood Transfus       Date:  2012-02-13       Impact factor: 3.443

4.  Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptide.

Authors:  Henrik Østergaard; Jais R Bjelke; Lene Hansen; Lars Christian Petersen; Anette A Pedersen; Torben Elm; Flemming Møller; Mette B Hermit; Pernille K Holm; Thomas N Krogh; Jørn M Petersen; Mirella Ezban; Brit B Sørensen; Mette D Andersen; Henrik Agersø; Haleh Ahmadian; Kristoffer W Balling; Marie Louise S Christiansen; Karin Knobe; Timothy C Nichols; Søren E Bjørn; Mikael Tranholm
Journal:  Blood       Date:  2011-06-23       Impact factor: 22.113

Review 5.  Prophylactic therapy in haemophilia.

Authors:  Rolf Ljung
Journal:  Blood Rev       Date:  2009-09-22       Impact factor: 8.250

6.  Factor VIII prophylaxis for adult patients with severe haemophilia A: results of a US survey of attitudes and practices.

Authors:  C E Walsh; L A Valentino
Journal:  Haemophilia       Date:  2009-06-01       Impact factor: 4.287

Review 7.  Prophylaxis in people with haemophilia.

Authors:  Antonio Coppola; Massimo Franchini; Annarita Tagliaferri
Journal:  Thromb Haemost       Date:  2009-04       Impact factor: 5.249

8.  A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group.

Authors:  L M Aledort; R H Haschmeyer; H Pettersson
Journal:  J Intern Med       Date:  1994-10       Impact factor: 8.989

9.  Should prophylaxis be used in adolescent and adult patients with severe haemophilia? An European survey of practice and outcome data.

Authors:  M Richards; C Altisent; A Batorova; H Chambost; G Dolan; P de Moerloose; M Fraga; C Hermans; A Karafoulidou; R Klamroth; R Lassila; C Rothschild
Journal:  Haemophilia       Date:  2007-09       Impact factor: 4.287

10.  Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.

Authors:  Marilyn J Manco-Johnson; Thomas C Abshire; Amy D Shapiro; Brenda Riske; Michele R Hacker; Ray Kilcoyne; J David Ingram; Michael L Manco-Johnson; Sharon Funk; Linda Jacobson; Leonard A Valentino; W Keith Hoots; George R Buchanan; Donna DiMichele; Michael Recht; Deborah Brown; Cindy Leissinger; Shirley Bleak; Alan Cohen; Prasad Mathew; Alison Matsunaga; Desiree Medeiros; Diane Nugent; Gregory A Thomas; Alexis A Thompson; Kevin McRedmond; J Michael Soucie; Harlan Austin; Bruce L Evatt
Journal:  N Engl J Med       Date:  2007-08-09       Impact factor: 91.245
View more
  5 in total

Review 1.  Present and future challenges in the treatment of haemophilia: the patient's perspective.

Authors:  Romano Arcieri; Angelo C Molinari; Stefania Farace; Giuseppe Mazza; Alberto Garnero; Gabriele Calizzani; Paola Giordano; Emily Oliovecchio; Lorenzo Mantovani; Lamberto Manzoli; Paul Giangrande
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

2.  Intermediate Dose Prophylaxis in Adults with Haemophilia: A Clinical Audit from a Resource Limited Setting.

Authors:  Remya Sudevan; Aswathy Ashok Beenakumari; Rema Ganapathy; Manoj Unni; Geeta Vidyadharan; Neeraj Sidharthan
Journal:  Indian J Hematol Blood Transfus       Date:  2019-09-18       Impact factor: 0.900

3.  Humanistic and economic aspects of haemophilia treatment in Bulgaria. Comparison between two therapeutic approaches: prophylactic vs. on-demand treatment.

Authors:  Guenka Petrova; Konstantin Tachkov; Svetla Georgieva; Maria Dimitrova
Journal:  Biotechnol Biotechnol Equip       Date:  2014-08-26       Impact factor: 1.632

Review 4.  Advancing personalized care in hemophilia A: ten years' experience with an advanced category antihemophilic factor prepared using a plasma/albumin-free method.

Authors:  Erik Berntorp; Gerald Spotts; Lisa Patrone; Bruce M Ewenstein
Journal:  Biologics       Date:  2014-04-05

5.  Understanding patient preferences and willingness to pay for hemophilia therapies.

Authors:  Shraddha S Chaugule; Joel W Hay; Guy Young
Journal:  Patient Prefer Adherence       Date:  2015-11-11       Impact factor: 2.711
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.